Phospho-mTOR (Ser2448) Antibody

About the Target

Phospho-mTOR (Ser 2448) refers to the phosphorylated form of the mammalian target of rapamycin (mTOR) at serine residue 2448, a modification crucial for its activation. mTOR, a serine/threonine kinase of the PI3K-related kinase family, integrates signals from growth factors, nutrients, and energy status to regulate cell growth, metabolism, and survival. Phosphorylation at Ser 2448, primarily mediated by the Akt pathway, enhances mTOR's activity, promoting downstream signaling such as p70S6 kinase activation and 4E-BP1 inhibition, leading to increased protein synthesis and anabolic processes. Depending on the literature source, MTOR may also be discussed as Phospho-mTOR (Ser2448) and mTOR (phospho S2448).

Reported cellular context includes cytoplasm, cytoplasmic vesicle, endoplasmic reticulum, and golgi apparatus, which can matter when signal is compared across treatments or changing cell states. Following MTOR across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.

Research Context

MTOR is commonly interpreted in the context of cancer, metabolism, and cell signaling research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cytoplasm, cytoplasmic vesicle, and endoplasmic reticulum, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.

Consider these angles when interpreting target-level changes:

• apparent redistribution between cytoplasm, cytoplasmic vesicle, and endoplasmic reticulum across matched conditions
• changes associated with proliferative state, oncogenic signaling, or treatment response
• responses linked to nutrient status, mitochondrial state, or metabolic rewiring
• signal-dependent shifts after ligand, inhibitor, or growth-factor perturbation

Variant Considerations

If your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for MTOR. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.

Standardize sampling time, control choice, and downstream analysis thresholds so apparent differences in MTOR reflect biology rather than handling. When interpreting MTOR, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.

For multi-run studies, a shared reference condition can keep MTOR trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.